Executive summary of the American Radium Society Appropriate Use Criteria: Regional nodal irradiation for breast cancer Guidelines


Authors: Expert Panel on Breast Cancer; Freedman, G. M.; Guttmann, D. M.; Ahmed, K.; Gao, W.; Walker, E. M.; Harris, E. E.; Gonzalez, V.; Ye, J.; Nead, K.; Taunk, N.; Tadros, A. B.; Dang, C. T.; Daroui, P.; Novick, K.
Title: Executive summary of the American Radium Society Appropriate Use Criteria: Regional nodal irradiation for breast cancer
Abstract: Objectives: Recent literature has provided additional data to further individualize treatment recommendations on regional nodal irradiation (RNI) patient selection and delivery techniques, but controversies surrounding optimal RNI utilization remain, including radiation technique, modality selection, and internal mammary lymph node (IMN) inclusion. The American Radium Society (ARS) Breast Appropriate Use Criteria (AUC) Committee performed a systematic review and developed a consensus guideline to summarize recent data and provide evidence-based recommendations. Methods: A multidisciplinary panel comprised of 15 members representing radiation oncologists, medical oncologists, and surgical oncologists specializing in the treatment of breast cancer conducted an analysis of the medical literature from January 1, 2011 to April 1, 2024. Modified Delphi methodology was used to rate the appropriateness of treatments for variants across 3 key questions. Results: Patients with intermediate-risk breast cancer, such as limited nodal involvement or large primary tumor size, are reasonable candidates for RNI, although a subset of patients with overall favorable clinicopathologic features may be considered for treatment de-escalation. Data on the use of advanced radiation techniques for RNI were limited in scope and strength, and the panel agreed that careful patient selection is needed when using these tools. Evidence suggests that the IMN should be included when delivering RNI given the absolute benefit demonstrated in multiple randomized trials. Conclusion: A systematic review and evidence-based summary of recommendations are provided in these consensus guidelines from the ARS Breast AUC Committee to provide current comprehensive guidance on the optimal management of non-metastatic breast cancer patients being considered for RNI. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: adult; cancer chemotherapy; cancer survival; event free survival; middle aged; medical oncologist; overall survival; clinical feature; intensity modulated radiation therapy; patient selection; united states; cancer radiotherapy; disease free survival; lymph node metastasis; antineoplastic agent; lymph nodes; lymphatic metastasis; sentinel lymph node biopsy; breast cancer; mastectomy; tumor volume; radiotherapy dosage; radiotherapy; epidermal growth factor receptor 2; evidence based practice; practice guideline; pathology; breast neoplasms; systematic review; breast tumor; lymph node; medical society; micrometastasis; tamoxifen; telangiectasia; photon therapy; intensity-modulated radiation therapy; meta analysis; completion axillary lymph node dissection; conformal radiotherapy; internal mammary nodes; skin fibrosis; proton therapy; lymphatic irradiation; human epidermal growth factor receptor 2 positive breast cancer; humans; human; female; article; surgical oncologist; radiation oncologist; internal mammary lymph node; regional nodal irradiation; hormone receptor negative breast cancer
Journal Title: American Journal of Clinical Oncology
Volume: 48
Issue: 3
ISSN: 0277-3732
Publisher: Lippincott Williams & Wilkins  
Date Published: 2025-03-01
Start Page: 111
End Page: 121
Language: English
DOI: 10.1097/coc.0000000000001154
PUBMED: 39761648
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding MSK author is J. Isabelle Choi -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Chau Dang
    271 Dang
  2. Audree Blythe Tadros
    116 Tadros